Terada, Y <br/><br/>
Cell cycle inhibitors (p27Kip1 and p21CIP1) cause hypertrophy in LLC-PK1 cells.  [electronic resource] 

 -  Kidney international  Aug 1999 
 - 494-501 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0085-2538 
<br/><br/><label>Standard No.: </label>10.1046/j.1523-1755.1999.00568.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae<br/>Angiotensin II--pharmacology<br/>Animals<br/>CDC2-CDC28 Kinases<br/>Carrier Proteins--genetics<br/>Cell Cycle Proteins<br/>Cell Size<br/>Cyclin-Dependent Kinase 2<br/>Cyclin-Dependent Kinase 4<br/>Cyclin-Dependent Kinase Inhibitor p15<br/>Cyclin-Dependent Kinase Inhibitor p16<br/>Cyclin-Dependent Kinase Inhibitor p21<br/>Cyclin-Dependent Kinase Inhibitor p27<br/>Cyclin-Dependent Kinases--metabolism<br/>Cyclins--genetics<br/>Enzyme Inhibitors--metabolism<br/>Gene Expression Regulation, Enzymologic<br/>Gene Expression Regulation, Viral<br/>Genetic Vectors<br/>Hypertrophy<br/>Kidney Diseases--enzymology<br/>LLC-PK1 Cells--drug effects<br/>Microtubule-Associated Proteins--genetics<br/>Protein Serine-Threonine Kinases--metabolism<br/>Proto-Oncogene Proteins<br/>Swine<br/>Tritium<br/>Tumor Suppressor Proteins<br/>Vasoconstrictor Agents--pharmacology<br/>beta-Galactosidase--genetics